AlpInvest Partners’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-21,104	Closed	-$371K	–	30
2019 Q1	$371K	Sell	21,104 -5,821	-22%	-$102K	0.5%	22
2018 Q4	$345K	Buy	+26,925	New	+$345K	0.99%	18